Markets
BSE See NSE See 39,599.19
164.25 (0.42%)
collapse Related Readings collapse

Mutual fund investments through SIPs

| 11/7/2011 9:46 AM Monday

- By T SRIKANTH BHAGAVAT
MD, Hexagon Capital Advisors


Q. I am a subscriber of DSIJ and read your article regularly. I find your guidance very useful and realistic. I have been investing
Rs 2500 per month through an SIP in the following funds since January 2010. I have chosen the Dividend Reinvestment Option for all funds, except for the IDFC Imperial Equity Fund Plan - A Growth Scheme.

1. HDFC Top 200
2. DSPBR Top 100 Equity Regular
3. UTI Opportunities
4. Morgan Stanley A.C.E.
5. Birla Sun Life Frontline Equity
6. Reliance Regular Savings
7. IDFC Imperial Equity Fund Plan - A, Growth

Please review my portfolio and suggest:
a) Whether the funds selected by me are proper
b) Whether the Dividend Reinvestment Option selected by me is proper, or whether I should switch over to the growth option

c) Whether I need to tweak my portfolio

- P P Dhamangaonkar, Pune

Currently, 57 per cent of your total funds are allocated to Large-Caps through SIPs. These are HDFC Top 200, DSPBR Top 100 Equity Fund, UTI Opportunities and IDFC Imperial Equity Fund Plan A. As such, the allocation is at a relatively low risk (among equities) – even if your Multi-Cap funds allocate half to Mid-Cap stocks, your overall allocation to Mid-Cap would have reached only20-30 per cent.

We recommend holding your investments in HDFC Top 200 and DSPBR Top 100, as these are funds with a consistent track record of success, delivering a CAGR that falls between 15-25 per cent over the last three-five years. On the other hand, we recommend exiting IDFC Imperial Equity. IDFC Imperial Equity has a much lower CAGR (than its peer group) of only 26 per cent and 10 per cent in the three and five year category.

A worthy inclusion would be the ICICI Prudential Focused Blue Chip Fund. Though running a concentrated portfolio, it has managed to deliver higher returns than other Large-Cap funds and also to keep volatility down. Note that the fund is just over three years old, but given its pedigree, it can be trusted to remain consistent in its philosophy and management. In the Multi-Cap space, Morgan Stanley A.C.E. and Birla SL (BSL) Frontline Equity have both been running higher risk portfolios, and adjusted for risk, have delivered lower returns than their peer group. Frontline though, has outperformed the Sensex. Similarly, Reliance Regular Savings Fund, which also falls into the Multi-Cap space, has been an underperformer, with a negative CAGR of 19.32 per cent and a relatively high standard deviation. Therefore, we suggest an exit from this fund too.

These SIPs can be redirected to the UTI Dividend Yield Fund, which is a low risk fund with a high risk-adjusted return. Another inclusion from the Mid-Cap space can be the IDFC Premier Equity Fund, which has delivered returns of 39 per cent (three years) and  22 per cent (five years) compounded annually but with a low standard deviation, indicating low risk. As to whether you should be in growth or dividend reinvestment, considering the present tax laws, there is no difference. For your size of portfolio though, I do think you could reduce the number of funds to just three or four.

 

Find More Articles on: DSIJ Magazine, Financial Guidance, Personal Finance, Mutual Funds, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Ducon Infra partners with Sterling & Wilson to bid for large GFD projects

Apurva Joshi / Article rating: 5.0

Ducon Infratechnologies Limited has entered into a strategic tie-up with Sterling & Wilson Private Limited, a flagship group company of Shapoorji Pallonji Group, to jointly bid large-sized FGD tenders. Ducon is an emerging technology company providing solutions in the industrial, infrastructure and digital space to multiple business segments across varied industries.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.